Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -28.17% | -86.47% | -53.89% | -59.07% | 16.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.17% | -86.47% | -53.89% | -59.07% | 16.48% |
| Cost of Revenue | 34.62% | -3.57% | -54.55% | 64.41% | -48.34% |
| Gross Profit | -35.54% | -90.56% | -53.94% | -118.29% | 36.34% |
| SG&A Expenses | 9.91% | -66.13% | 60.46% | -25.62% | -11.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.35% | -64.20% | 49.67% | -20.21% | -15.41% |
| Operating Income | -60.91% | 23.36% | -315.54% | 11.38% | 36.93% |
| Income Before Tax | -47.17% | -8.26% | -55.78% | 8.03% | 36.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.17% | -8.26% | -55.78% | 8.03% | 36.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.17% | -8.26% | -55.78% | 8.03% | 36.09% |
| EBIT | -60.91% | 23.36% | -315.54% | 11.38% | 36.93% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 10.76% | 11.17% | 8.01% | 3.41% | 1.60% |
| Average Diluted Shares Outstanding | 10.76% | 11.17% | 8.01% | 3.41% | 1.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |